Navigation Links
Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
Date:5/16/2013

NEW YORK, May 16, 2013 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (OTCBB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for treatment of advanced cancers, announced that the official program of TAT: Target Alpha Therapy (TAT) international symposium will feature a presentation devoted to Actinium Pharmaceuticals' clinical programs.  The abstract entitled "Alpha-Particle Immunotherapy for Acute Myeloid Leukemia with Bismuth-213 and Actinium-225" has been accepted for oral presentation to be delivered by Dr. Joseph Jurcic , Chief of Leukemia Services at New York Presbyterian/Columbia.

"Alpha emitters offer the possibility of more efficient leukemia cell killing without the toxicity of intensive chemotherapy," said Dr. Jurcic.  "We are now studying this modality in combination with low-dose chemotherapy in older AML patients for whom new treatments are desperately needed.   The average age for AML patients is 68.  Most of these patients cannot tolerate intensive treatments, and their prognosis is extremely poor.  A drug like Actimab-A™ could allow them to avoid the side effects of standard chemotherapy."

Dr. Jurcic's presentation will focus on Actinium Pharmaceuticals' drug candidates Actimab-A™ and Bismab.  It will take place during the 8th Targeted Alpha Therapy (TAT) international symposium that will be held in Oak Ridge, TN.

About Actimab-A™

Actimab-A™ is a drug candidate construct made using Actinium Pharmaceuticals' proprietary patented technology for arming monoclonal antibodies with alpha emitters actinium 225 and bismuth 213.  Antibodies are used as high precision delivery systems that bring powerful alpha emitters into or immediately next to targeted cancer cells.  Actimab-A™ con
'/>"/>

SOURCE Actinium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
2. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
3. Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference
4. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
5. University of Pennsylvania joins Actinium Pharmaceuticals Multicenter Actimab-A Trial
6. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
7. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
8. Actinium Pharmaceuticals Announces New Round of Financing
9. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
10. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
11. Actinium Pharmaceuticals Stockholders Vote to Approve Fundraising and Public Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)...  Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... on September 10, 2015. DATE: Thursday, September ... http://tinyurl.com/sep10pre This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:9/4/2015)... (NYSE: AGN ) a leading global pharmaceutical company, today ... Allergan, will provide an overview and update of the Company,s ... New York, NY . Logo ... take place on Thursday, September 17, 2015 at 10:35 AM ... 42nd Street, New York, NY 10017.  ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... , , INCLINE VILLAGE, Nev., Dec. 2 PDL ... has established the per share amount of the previously announced $200 ... paid on December 15, 2009 to all holders of the Company,s ... previously estimated the approximate per share amount of the dividend at ...
... , NANJING, China, ... "Company") (NYSE: SCR ), a leading pharmaceutical ... and proprietary pharmaceuticals in China, today reported that its,subsidiary ... suspended production of all its products in order to ...
Cached Medicine Technology:PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3
(Date:9/4/2015)... ... ... According to an article published August 18th on Neurology Advisor, ... force that is great enough to cause a traumatic brain injury. This new polymer, ... coaches or officials would instantly see if a player may have suffered a head ...
(Date:9/4/2015)... Diego, California (PRWEB) , ... September 04, 2015 , ... ... on behalf of Tanya De La Paz. , Schmidt National Law Group, a ... the Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today that ... of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , ... the consumer goods industry, it can be difficult for companies to navigate, stay ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily ... to explore, revitalize and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager ... Seasons Resort Maui, the island’s only Forbes Five Star resort and Travel + Leisure’s ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference ... in Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has ... are doctors and researchers at the top of their field and will be ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... the United States suggests that the odds of firefighters dying ... fire, //are 10 to 100 times higher than during non-emergency ... ,Stefanos Kales of Harvard Medical School and colleagues say ... in smoke, and lack of physical fitness appeared responsible for ...
... a flight attendant. She started exercising two years back and ... keen that she be agile and strong. ,She ... Her exercise regimen includes balancing on one leg, working with ... fall and break her bones. ,Health experts ...
... used ingredient in the Indian curry powder, could be ... ,ASC-J9, a synthetic chemical compound, derived from ... considerable promise against prostate cancer, acne, and enlarged prostate, ... researchers at the University of Rochester Medical Center ...
... Larry E. Miller and team from Virginia Polytechnic Institute and ... men after one year of coronary artery bypass grafting (CABG). ... than one coronary artery which pass through the heart to ... Twenty six men between the ages of 50 and 79 ...
... only recorded case, turns a mild mannered 70-year-old man into a ... his wife have ‘nightmares’ during the day, of the night to ... after, a different person. He shouts, uses the foulest language, sleepwalks, ... Rogers has broken his nose thrice, ...
... people are turning to the Internet to find information, important ... sheer avalanche of facts// now available online. Key science sites ... results. ,New research funded by the Economic and ... Web to make their information available must now pay attention ...
Cached Medicine News:Health News:New Study Reveals That Firefighters Are Prone To Heart Attack 2Health News:Key Science Web Sites Buried in Information Avalanche 2
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
... Stabilizer Plastazote® with plastic anterior ... straps. Chin cradle reduces rotation. ... be interchanged for individualized fitting.,Philadelphia™ ... standard Philadelphia Collar for added ...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Optical Mini Urethrotome for telescope 3.3 mm, 0...
Medicine Products: